328 related articles for article (PubMed ID: 715173)
1. The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management.
Gibbs K; Hanka R; Walshe JM
Q J Med; 1978 Jul; 47(187):349-64. PubMed ID: 715173
[TBL] [Abstract][Full Text] [Related]
2. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
Walshe JM
QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
[TBL] [Abstract][Full Text] [Related]
3. Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members.
Merli M; Patriarca M; Loudianos G; Valente C; Riggio O; De Felice G; Petrucci F; Caroli S; Attili AF
Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):270-5. PubMed ID: 9759594
[TBL] [Abstract][Full Text] [Related]
4. Urinary copper excretion before and after oral intake of d-penicillamine in parents of patients with Wilson's disease.
Vieira J; Oliveira PV; Juliano Y; Warde KR; Deguti MM; Barbosa ER; Carrilho FJ; Cancado EL
Dig Liver Dis; 2012 Apr; 44(4):323-7. PubMed ID: 22169274
[TBL] [Abstract][Full Text] [Related]
5. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
6. [Wilson' disease: rapid diagnosis and differentiation of heterozygous and homozygous carriers with 64CuCl2 (author's transl)].
Wesch H; Przuntek H; Feist D
Dtsch Med Wochenschr; 1980 Apr; 105(14):483-8. PubMed ID: 7363808
[TBL] [Abstract][Full Text] [Related]
7. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
Prasad R; Kaur G; Walia BN
Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
[TBL] [Abstract][Full Text] [Related]
8. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
Marecek Z; Heyrovský A; Volek V
Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
[TBL] [Abstract][Full Text] [Related]
9. [The role of zinc in the initial treatment of Wilson's disease in children].
Cacić M; Percl M; Jadresin O; Kolacek S
Lijec Vjesn; 2000 Mar; 122(3-4):77-81. PubMed ID: 10932534
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis.
Brewer GJ; Dick RD; Yuzbasiyan-Gurkan V; Johnson V; Wang Y
J Lab Clin Med; 1994 Jun; 123(6):849-58. PubMed ID: 8201263
[TBL] [Abstract][Full Text] [Related]
11. Syndromic variability of Wilson's disease in children. Clinical study of 44 cases.
Giacchino R; Marazzi MG; Barabino A; Fasce L; Ciravegna B; Famularo L; Boni L; Callea F
Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):155-61. PubMed ID: 9646197
[TBL] [Abstract][Full Text] [Related]
12. Wilson's disease: a new gene and an animal model for an old disease.
Cuthbert JA
J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of Wilson's disease: results of a single center experience.
Medici V; Trevisan CP; D'Incà R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
[TBL] [Abstract][Full Text] [Related]
14. [Wilson's disease ("hepatic form") in a region endemic for schistosomiasis mansoni: clinical presentation of 25 patients].
Galizzi-Filho J; Andrade Mde O; Cota Mde M; Penna FJ; Figueiredo-Filho PP; Valadares CA; Machado-Silva R; Barquete J; de Oliveira JP; de Almeida JA
Arq Gastroenterol; 1998; 35(1):11-7. PubMed ID: 9711308
[TBL] [Abstract][Full Text] [Related]
15. Wilson's disease (hepatolenticular degeneration) of late adult onset: report of case.
Fitzgerald MA; Gross JB; Goldstein NP; Wahner HW; McCall JT
Mayo Clin Proc; 1975 Aug; 50(8):438-42. PubMed ID: 1152537
[TBL] [Abstract][Full Text] [Related]
16. Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children.
Müller T; Koppikar S; Taylor RM; Carragher F; Schlenck B; Heinz-Erian P; Kronenberg F; Ferenci P; Tanner S; Siebert U; Staudinger R; Mieli-Vergani G; Dhawan A
J Hepatol; 2007 Aug; 47(2):270-6. PubMed ID: 17449133
[TBL] [Abstract][Full Text] [Related]
17. Use of whole-body counter to study body retention of radiocopper in Wilson's disease.
Hamamoto K; Tauxe WN; Novak LP; Goldstein NP
J Lab Clin Med; 1968 Nov; 72(5):754-9. PubMed ID: 5697385
[No Abstract] [Full Text] [Related]
18. Long-term body retention of radiocopper (67Cu) and the diagnosis of Wilson's disease.
Willvonseder R; Goldstein NP; Tauxe WN
Mayo Clin Proc; 1974 Jun; 49(6):387-93. PubMed ID: 4835809
[No Abstract] [Full Text] [Related]
19. The pattern of the whole body distribution of radioactive copper (67Cu, 64Cu) in Wilson's Disease and various control groups.
Walshe JM; Potter G
Q J Med; 1977 Oct; 46(184):445-62. PubMed ID: 413153
[No Abstract] [Full Text] [Related]
20. Diagnosis and characterization of presymptomatic patients with Wilson's disease and the use of molecular genetics to aid in the diagnosis.
Yuzbasiyan-Gurkan V; Johnson V; Brewer GJ
J Lab Clin Med; 1991 Nov; 118(5):458-65. PubMed ID: 1940586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
